Defence Therapeutics Inc (DTC.CN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 06/30
| 03-2023 | 12-2022 | 09-2022 | 06-2022 | 03-2022 | |
| Operating Expenses | 1,242 | 1,913 | 1,663 | 2,172 | 1,677 |
| Operating Income | -1,242 | -1,913 | -1,663 | -2,172 | -1,677 |
| Interest Expense | 108 | 51 | N/A | N/A | N/A |
| Other Income | 7 | -24 | 39 | 6 | 17 |
| Pre-tax Income | -1,343 | -1,988 | -1,624 | -2,165 | -1,660 |
| Net Income Continuous | -1,343 | -1,988 | -1,624 | -2,165 | -1,660 |
| Net Income | $-1,343 | $-1,988 | $-1,703 | $-2,178 | $-1,695 |
| EPS Basic Total Ops | -0.03 | -0.05 | -0.05 | -0.06 | -0.05 |
| EPS Basic Continuous Ops | -0.03 | -0.05 | -0.05 | -0.06 | -0.05 |
| EPS Diluted Total Ops | -0.03 | -0.05 | -0.05 | -0.06 | -0.05 |
| EPS Diluted Continuous Ops | -0.03 | -0.05 | -0.05 | -0.06 | -0.05 |
| EBITDA(a) | $-1,234 | $-1,924 | $-1,663 | $-2,172 | $-1,677 |